Logo image of NXE.CA

NEXGEN ENERGY LTD (NXE.CA) Stock Fundamental Analysis

TSX:NXE - Toronto Stock Exchange - CA65340P1062 - Common Stock - Currency: CAD

9.54  -0.01 (-0.1%)

Fundamental Rating

2

NXE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 214 industry peers in the Oil, Gas & Consumable Fuels industry. The financial health of NXE is average, but there are quite some concerns on its profitability. NXE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NXE had negative earnings in the past year.
In the past year NXE has reported a negative cash flow from operations.
NXE had negative earnings in 4 of the past 5 years.
NXE had a negative operating cash flow in each of the past 5 years.
NXE.CA Yearly Net Income VS EBIT VS OCF VS FCFNXE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

NXE has a Return On Assets of -5.99%. This is comparable to the rest of the industry: NXE outperforms 40.65% of its industry peers.
The Return On Equity of NXE (-8.51%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -5.99%
ROE -8.51%
ROIC N/A
ROA(3y)-2.29%
ROA(5y)-11.88%
ROE(3y)-3.42%
ROE(5y)-30.84%
ROIC(3y)N/A
ROIC(5y)N/A
NXE.CA Yearly ROA, ROE, ROICNXE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

NXE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NXE.CA Yearly Profit, Operating, Gross MarginsNXE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, NXE has more shares outstanding
The number of shares outstanding for NXE has been increased compared to 5 years ago.
The debt/assets ratio for NXE is higher compared to a year ago.
NXE.CA Yearly Shares OutstandingNXE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
NXE.CA Yearly Total Debt VS Total AssetsNXE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 6.61 indicates that NXE is not in any danger for bankruptcy at the moment.
NXE has a Altman-Z score of 6.61. This is amongst the best in the industry. NXE outperforms 88.78% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that NXE is not too dependend on debt financing.
NXE has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. NXE outperforms 81.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.61
ROIC/WACCN/A
WACCN/A
NXE.CA Yearly LT Debt VS Equity VS FCFNXE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

NXE has a Current Ratio of 0.97. This is a bad value and indicates that NXE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of NXE (0.97) is better than 61.68% of its industry peers.
NXE has a Quick Ratio of 0.97. This is a bad value and indicates that NXE is not financially healthy enough and could expect problems in meeting its short term obligations.
NXE has a better Quick ratio (0.97) than 66.82% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.97
NXE.CA Yearly Current Assets VS Current LiabilitesNXE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

NXE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.52%, which is quite impressive.
EPS 1Y (TTM)65.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%183.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

NXE is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.41% yearly.
The Revenue is expected to grow by 210.79% on average over the next years. This is a very strong growth
EPS Next Y33.41%
EPS Next 2Y11.51%
EPS Next 3Y-2.19%
EPS Next 5Y2.41%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y210.79%

3.3 Evolution

NXE.CA Yearly Revenue VS EstimatesNXE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2024 2028 2029 2030 2031 2032 1B 2B 3B
NXE.CA Yearly EPS VS EstimatesNXE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.1 -0.2 -0.3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NXE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NXE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXE.CA Price Earnings VS Forward Price EarningsNXE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXE.CA Per share dataNXE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A cheap valuation may be justified as NXE's earnings are expected to decrease with -2.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.51%
EPS Next 3Y-2.19%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NXE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEXGEN ENERGY LTD

TSX:NXE (7/18/2025, 7:00:00 PM)

9.54

-0.01 (-0.1%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners54.47%
Inst Owner ChangeN/A
Ins Owners4.54%
Ins Owner ChangeN/A
Market Cap5.43B
Analysts81.11
Price Target13.67 (43.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)41.07%
Min EPS beat(2)-159.31%
Max EPS beat(2)241.44%
EPS beat(4)3
Avg EPS beat(4)46.25%
Min EPS beat(4)-159.31%
Max EPS beat(4)241.44%
EPS beat(8)3
Avg EPS beat(8)-51.8%
EPS beat(12)4
Avg EPS beat(12)-131.16%
EPS beat(16)4
Avg EPS beat(16)-158.46%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.34%
PT rev (3m)-1.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.93
P/tB 4.93
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS1.94
TBVpS1.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.99%
ROE -8.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-2.29%
ROA(5y)-11.88%
ROE(3y)-3.42%
ROE(5y)-30.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5461.66%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.97
Altman-Z 6.61
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)5324.66%
Cap/Depr(5y)3796.13%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%183.33%
EPS Next Y33.41%
EPS Next 2Y11.51%
EPS Next 3Y-2.19%
EPS Next 5Y2.41%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y210.79%
EBIT growth 1Y45.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-2.72%
EBIT Next 3Y3.55%
EBIT Next 5Y9.62%
FCF growth 1Y-41.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.5%
OCF growth 3YN/A
OCF growth 5YN/A